| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| July 23rd, 2004 | 16 | No |
Popular Name: Aniracetam Aniracetam
Find On: PubMed — Wikipedia — Google
CAS Numbers: 72432-10-1 , [72432-10-1]
1-(4-Methoxy-benzoyl)-pyrrolidin-2-one
72432-10-1; Aniracetam (JAN/USAN/INN); D01883
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 0.69 | 5.63 | -19.04 | 0 | 4 | 0 | 47 | 219.24 | 2 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| mechanism | . | ZereneX Building Blocks |
| ALOGPS_SOLUBILITY | 2.47e+00 g/l | DrugBank-experimental |
| Target | AMPA Receptor-kainate Receptor-NMDA Receptor | Selleck Chemicals |
| biological_use | Antidepressant | IBScreen Bioactives |
| biological_use | Antidepressive agent | ZereneX Building Blocks |
| biological_use | Anxiolytic | IBScreen Bioactives |
| therap | cognitive enhancer | MicroSource Spectrum |
| mechanism | Dopamine D2 receptor agonist | IBScreen Bioactives |
| Patent Database Links | EP1356812; US2006276462; WO2007137227 | ChEBI |
| Therapy | Increases ion conductance through AMPA glutamate receptors; reported to display | SMDC Iconix |
| mechanism | Nicotinic acetylcholine (nACh) receptor agonist | IBScreen Bioactives |
| biological_use | Nootropic | IBScreen Bioactives IBScreen Bioactives |
| mechanism | Selective AMPA receptor modulator | IBScreen Bioactives IBScreen Bioactives |
| mechanism | Serotonin (5-HT2A) receptor agonist | IBScreen Bioactives |
